bioconjugate – Inorganic Nanoparticles Group

Joan and Lorena have defended their PhD theses!

Editor — Mon, 22 Jul 2013 16:49:32 +0000

Joan Comenge has successfully defended his PhD thesis entitled “Gold Nanoparticles as Drug Delivery Agents: Detoxifying the Chemotherapeutic Drug Cisplatin”, last Thursday July 18. The PhD Committee was formed by Dr. Teresa Pellegrino (Nanoscience Institute, CNR, Italy), Prof. Fernando Dominguez (Universidad Santiago de Compostela, Spain), and Prof. Jaume Farrés (Universitat Autònoma de Barcelona, Spain).

Lorena García also successfully defended her PhD thesis entitled “Introducing gold nanoparticle bioconjugates within the biological machinery”, the next day Friday July 19. In this case, the PhD Committee was formed by Prof. Wolfgang Parak (Philipps-Universität Marburg, Germany), Prof. Jesús M. de la Fuente (Universidad de Zaragoza, Spain) and Dr. Julia Lorenzo (Institut de Biotecnologia i Biomedicina, UAB, Spain).

Congratulations Joan and Lorena!!!

Our participation at the 5th European Conference on Chemistry for Life Sciences (5th ECCLS)

Editor — Sun, 02 Jun 2013 20:52:48 +0000

Sofía Rubio, PhD student in our group, will participate in the 5th European Conference on Chemistry for Life Sciences (5th ECCLS), which will be held in Barcelona, Spain, on June 10-12, 2013. This conference is an activity of the EuCheMS (European Association for Chemical and Molecular Sciences) Division of Chemistry in Life Sciences.

Sofía will contribute to the conference with the poster “The same formulation, a different effect. Controlling conformation of NanoBioconjugates”.

Víctor Puntes featured in newspaper La Vanguardia for nanobiomedicine entrepreneurship

Editor — Sat, 05 May 2012 20:19:41 +0000

Prof. Víctor Puntes has been featured in an article in La Vanguardia, a local newspaper, in relation to our research on bioconjugated nanoparticles for drug delivery. For several years, Víctor and several members of our group, together with collaborators, have been carrying on a project on bioconjugation of gold nanoparticles for delivery of cisplatin, an anti-cancer drug. This work has led to a patent that has been now licensed to the Swiss company Nanonica, to create the start-up Nanotargeting as joint venture between Nanonica, ICN, and Ferrer Group.

This story, being an excellent example of technology transfer and entrepreneurship in the biotechnological field, was fully covered by the local newspaper La Vanguardia in the article “Gold in nanotechnology”, by Rosa Salvador, published on May 2, 2012.

Read the full article here (in Spanish)

New paper on the protein corona formation on bioconjugated gold nanoparticles

Editor — Mon, 02 Apr 2012 18:16:51 +0000

A new paper is out on the study of the protein corona formation and the thermal denaturalization in bioconjugated gold nanoparticles. The work was led by the Colloids and Polymers Physics Group from the Universidad de Santiago de Compostela (USC), and resulted from a collaboration between Eudald Casals, Víctor Puntes, and Sonia Goy, who is currently a visiting researcher from USC at our group in Barcelona. Congratulations on this joint work!

Physicochemical Characteristics of Protein–NP Bioconjugates: The Role of Particle Curvature and Solution Conditions on Human Serum Albumin Conformation and Fibrillogenesis Inhibition. S. Goy-López, J. Juárez, M. Alatorre-Meda, E. Casals, V.F. Puntes, P. Taboada, V. Mosquera. Langmuir (DOI 10.1021/la300402w), 2012:

http://pubs.acs.org/doi/full/10.1021/la300402w